Table 2.
Outcome | Control day | Estradiol day | P value |
---|---|---|---|
E2 (pg/ml) | |||
Baseline | 19 ± 5 | 249 ± 142 | <0.001 |
End stage | 16 ± 4 | 288 ± 157 | <0.001 |
Glucose (mg/dl) | |||
Baseline | 98 ± 8 | 93 ± 6 | 0.004 |
End stage | 250 ± 9 | 257 ± 9 | 0.158 |
INSAUC (μU/ml × min) | |||
End stage | 11,806 ± 6,754 | 11,226 ± 5,395 | 0.719 |
CPEPAUC (ng/ml × min) | |||
End stage | 787 ± 138 | 798 ± 214 | 0.807 |
C-peptide to insulin ratio | |||
End stage | 4.1 ± 2.6 | 3.7 ± 1.2 | 0.662 |
Baseline, fasted (0 min). End stage, 90–120 min averages or areas under the curves. Systeme International unit conversion factors: E2 (3.671, pmol/liter); glucose (0.0555, mmol/liter); INS (7.175, pmol/liter); and CPEP (1, μg/liter).